p53-dependent CD51 expression contributes to characteristics of cancer stem cells in prostate cancer
Authors:
Open Access
- 9 May 2018
- journal article
- research article
- Published by Springer Nature in Cell Death & Disease
- Vol. 9 (5) , 1-15
Abstract
: Castration-resistant prostate cancer (CRPC), which is considered to contain cancer stem cells (CSCs), leads to a high relapse rate in patients with prostate cancer (PCa). However, the markers of prostate CSCs are controversial. Here we demonstrate that CD51, in part, correlates with the poor prognosis of PCa patients. Further, we find that CD51 is a functional molecule that is able to promote the malignancy of PCa through enhancing tumor initiation, metastatic potential, and chemoresistance. Moreover, we find that elevated CD51 expression in PCa specimens correlates with p53 loss of function. Mechanistically, we demonstrate that p53 acts via Sp1/3 to repress CD51 transcription, and CD51 is required for PCa stemness and metastasis properties, and is downregulated by p53. Taken together, these results indicate that CD51 is a novel functional marker for PCa, which may provide a therapeutic target for the efficiently restricting PCa progression.Keywords
This publication has 53 references indexed in Scilit:
- The Role of miR-18b in MDM2-p53 Pathway Signaling and Melanoma ProgressionJNCI: Journal of the National Cancer Institute, 2013
- β4 Integrin signaling induces expansion of prostate tumor progenitorsJournal of Clinical Investigation, 2013
- E2F7, a novel target, is up-regulated by p53 and mediates DNA damage-dependent transcriptional repressionGenes & Development, 2012
- The PSA−/lo Prostate Cancer Cell Population Harbors Self-Renewing Long-Term Tumor-Propagating Cells that Resist CastrationCell Stem Cell, 2012
- The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44Nature Medicine, 2011
- Mechanisms of estrogen receptor antagonism toward p53 and its implications in breast cancer therapeutic response and stem cell regulationProceedings of the National Academy of Sciences of the United States of America, 2010
- NANOG regulates glioma stem cells and is essential in vivo acting in a cross‐functional network with GLI1 and p53The EMBO Journal, 2010
- Suppression of induced pluripotent stem cell generation by the p53–p21 pathwayNature, 2009
- Growth-Inhibitory and Tumor- Suppressive Functions of p53 Depend on Its Repression of CD44 ExpressionCell, 2008
- RegRNA: an integrated web server for identifying regulatory RNA motifs and elementsNucleic Acids Research, 2006